Your browser is no longer supported. Please, upgrade your browser.
BioCardia, Inc.
Index- P/E- EPS (ttm)-1.67 Insider Own8.90% Shs Outstand13.30M Perf Week-4.90%
Market Cap52.34M Forward P/E- EPS next Y-1.02 Insider Trans0.25% Shs Float8.22M Perf Month-21.43%
Income-15.00M PEG- EPS next Q-0.24 Inst Own10.90% Short Float5.12% Perf Quarter-33.87%
Sales0.10M P/S523.38 EPS this Y43.10% Inst Trans1.35% Short Ratio2.98 Perf Half Y71.88%
Book/sh1.44 P/B2.29 EPS next Y-2.00% ROA-119.00% Target Price- Perf Year-18.92%
Cash/sh1.35 P/C2.45 EPS next 5Y- ROE-204.90% 52W Range1.91 - 8.60 Perf YTD-4.62%
Dividend- P/FCF- EPS past 5Y47.90% ROI-78.20% 52W High-60.70% Beta1.84
Dividend %- Quick Ratio5.30 Sales past 5Y-30.70% Gross Margin97.20% 52W Low76.96% ATR0.22
Employees24 Current Ratio5.30 Sales Q/Q-78.60% Oper. Margin- RSI (14)39.87 Volatility6.41% 5.71%
OptionableYes Debt/Eq0.00 EPS Q/Q56.40% Profit Margin- Rel Volume0.32 Prev Close3.30
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume141.34K Price3.38
Recom2.00 SMA20-5.85% SMA50-13.23% SMA2004.62% Volume14,585 Change2.42%
Apr-16-21Downgrade Dawson James Buy → Neutral
May-13-21 08:00AM  
Apr-26-21 08:00AM  
Apr-01-21 01:52AM  
Mar-30-21 09:15AM  
Mar-15-21 08:00AM  
Feb-23-21 08:00AM  
Feb-17-21 08:30AM  
Feb-02-21 08:30AM  
Jan-11-21 08:30AM  
Dec-30-20 08:30AM  
Dec-17-20 08:30AM  
Dec-16-20 09:55AM  
Dec-15-20 01:21AM  
Dec-14-20 03:21PM  
Dec-01-20 07:00AM  
Nov-10-20 07:00AM  
Oct-26-20 07:30AM  
Oct-20-20 07:05AM  
Sep-29-20 08:00AM  
Aug-31-20 06:12PM  
Aug-26-20 07:00AM  
Aug-13-20 07:00AM  
Aug-12-20 12:30PM  
Aug-07-20 08:00AM  
Aug-05-20 11:15AM  
Jul-22-20 06:51AM  
Jul-01-20 10:20AM  
Jun-29-20 08:00AM  
Jun-17-20 08:30AM  
May-15-20 08:00AM  
May-05-20 07:00AM  
Apr-30-20 08:00AM  
Apr-28-20 03:08PM  
Apr-14-20 08:00AM  
Apr-09-20 02:03PM  
Apr-02-20 08:00AM  
Mar-31-20 08:00AM  
Mar-29-20 08:58AM  
Mar-12-20 08:00AM  
Feb-13-20 06:30AM  
Jan-14-20 08:00AM  
Jan-08-20 08:00AM  
Dec-30-19 10:40AM  
Nov-19-19 05:24PM  
Nov-11-19 07:44AM  
Oct-28-19 08:00AM  
Oct-08-19 08:00AM  
Oct-02-19 08:00AM  
Oct-01-19 08:00AM  
Sep-16-19 08:00AM  
Aug-21-19 08:00AM  
Aug-08-19 08:30AM  
Aug-06-19 04:05PM  
Aug-02-19 09:45AM  
Jul-25-19 06:00AM  
Jun-12-19 08:00AM  
Jun-06-19 08:00AM  
May-23-19 03:23PM  
May-20-19 08:00AM  
May-08-19 08:00AM  
Apr-02-19 08:00AM  
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and ALLOGENEIC cell therapy for cardiac and pulmonary disease. The company is also developing ALLOGENEIC Cell Therapy System, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system, a percutaneous catheter delivery system for cardiovascular regenerative medicine; and Morph deflectable guides and sheaths. The company is based in San Carlos, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Altman PeterPresident and CEODec 01Buy2.491,0002,488207,400Dec 01 09:34 PM
Altman PeterPresident and CEONov 27Buy2.373,2007,580206,400Dec 01 09:34 PM
Altman PeterPresident and CEONov 27Sale2.313,2007,380203,200Dec 01 09:34 PM
Altman PeterPresident and CEONov 13Buy2.095001,046206,400Nov 13 06:33 PM
Altman PeterPresident and CEONov 12Buy2.062,0004,130205,900Nov 13 06:33 PM
Altman PeterPresident and CEONov 10Buy1.982,5004,950203,900Nov 12 06:15 AM
Duckers EricChief Medical OfficerNov 02Sale2.018,43516,95412,088Nov 03 06:06 PM
Allen Jim L.DirectorJun 19Buy2.10142,850299,985668,200Jun 23 09:22 PM
STERTZER SIMON HDirectorJun 19Buy2.10142,850299,985187,983Jun 23 09:21 PM
Blank Andrew ScottDirectorJun 19Buy2.10142,850299,985142,850Jun 23 09:22 PM